Top Cancer Stocks in South Korea
Browse the largest South Korea companies in the world ranked by their Market Capitalization. Global Cancer Companies in South Korea market cap is $5.44B.
21 Jan 2025, 03:25 UTC
Companies: 16
🇰🇷1 |  | $183.42 | 0.38% | 2.33B | -24.33% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇰🇷2 |  | $42.99 | 0.80% | 1.22B | -23.63% | Underperform S&P500 YTD Benchamark | 🦾 AI | - |
🇰🇷3 |  | $19.51 | 4.79% | 934.29M | 14.49% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷4 |  | $1.21 | -0.28% | 167.52M | -27.01% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇰🇷5 |  | $3.68 | -2.72% | 152.34M | -46.40% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷6 |  | $7.04 | -2.19% | 142.38M | -55.15% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷7 |  | $1.70 | 2.27% | 119.69M | -58.96% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷8 |  | $4.90 | -1.38% | 92.25M | -14.78% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷9 |  | $4.22 | -1.13% | 58.43M | -48.23% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷10 |  | $2.08 | -4.25% | 58.19M | -29.95% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷11 |  | $3.57 | -6.14% | 48.50M | 16.33% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷12 |  | $4.58 | 0.00% | 35.82M | N/A | S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷13 |  | $0.95 | -2.52% | 31.58M | -47.45% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷14 |  | $0.41 | -3.23% | 21.72M | -50.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷15 |  | $0.83 | 0.17% | 14.67M | -43.19% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷16 |  | $1.36 | -0.05% | 9.94M | -40.63% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
